Over the past few years, cannabidiol has permeated the mainstream, cultivating a following of thousands of grateful consumers. Although the legal CBD industry is just a year old, it’s already worth millions of dollars in sales, and experts say it will hit $20 billion by 2024. Why is it so popular?
Well, according to the anecdotal evidence, CBD is chock-full of potent medicinal properties, and it’s capable of acting against a variety of conditions ranging from insomnia and high blood pressure to chronic pain and anxiety.
Ozzy Osborne, legendary rocker and lead vocalist of the heavy metal band Black Sabbath, is among the people using CBD for its therapeutic effects. The Prince of Darkness, as he’s affectionately called by his fans, began using CBD after being hit by a series of illnesses after being injured, and according to his wife and manager Sharon Osborne, he’s been using cannabidiol to combat the pain.
Another rock legend who’s turned to CBD is Grammy-winning guitarist and long-time cannabis advocate Carlos Santana. This year, he announced that he would be launching a CBD and cannabis brand in partnership with Left Coast Ventures. They are among the growing number of musicians who’ve been turning to CBD for a variety of reasons.
Anti-inflammatory. Touring puts a ton of strain on an artist’s body, especially metal vocalists who go all out with their vocals. After a while, the strain leads to inflammation of the vocal cords. Guitarists and drummers aren’t immune, as the repetitive movements from playing songs also lead to inflammation.
CBD is a potent anti-inflammatory, and it interacts with the endocannabinoid system to reduce inflammation and any resulting pain.
Stress relief is another sound reason, and CBD has a good track record reducing stress. The life of a rockstar can be stressful, especially during a tour, and such chronic stress can lead to substance abuse, muscle pain, heart disease, and other issues. Cannabidiol is believed to reduce the brain’s production of the stress hormone cortisol and increase the production of serotonin and dopamine.
Improves sleep. Life on the road can be hard, and it can affect the quality of sleep and lead to insomnia. Without enough sleep, an artist won’t be able to perform at 100%. On top of that, they will undoubtedly suffer physical symptoms like exhaustion, lack of focus and irritability. Cannabidiol works by interacting with the endocannabinoid system (ECS), a nervous system in charge of functions like sleep and pain.
On top of boosting the ECS, CBD’s anti-anxiety and pain-relieving properties induce a state of relaxation that makes it easier to fall asleep more deeply and for longer.
It is therefore no wonder when experts agree with industry actors, such as No Borders Inc. (OTC: NBDR), who say that CBD has immense potential in alleviating many of the health complaints suffered by different categories of people.
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
